FdaApplication
NDA 022405
Identifiers
- fda_app_no: NDA022405
Properties
| Property | Value |
|---|---|
| applicant_name | GENZYME CORP |
| application_type | NDA |
| approval_date | 2011-04-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CAPRELSA | VANDETANIB | 300MG | TABLET;ORAL |
| CAPRELSA | VANDETANIB | 100MG | TABLET;ORAL |
2 products